IGF1-LR3

IGF1-LR3, also called Long [Arg3]-IGF-I, is a modified analogue of insulin-like growth factor I. It has been studied for its interaction with IGF receptors and IGF-binding proteins.

Laboratory studies show that changes in binding-protein interactions can affect its biological activity in cell cultures. Findings from these experiments should not be interpreted as established clinical benefits for this product.